Dr Newman is lead for NeuroCoRe and lead on the development of all NeuroCoRe Apps. He is the mHealth Innovation Lead & Snr Res Fellow Plymouth University Peninsula Schools of Medicine and Dentistry and a Clinical Psychologist in the Neuropsychology department at Derriford Hospital, Plymouth. He gained a PhD in Applied Behavioural Economics at Keele medical school, before completing a doctorate in Clinical Psychology at Plymouth University. His research has focused on techology solutions to health assessment. He has specialised in mHealth product management with a range of skills including feasibility assessment, usability research, wireframing, graphic design and software development project management. His specialist interest is in human interaction and design in the delivery of a range of mHealth solutions.
Dr Rupert Noad - Trials lead
Dr Rupert Noad is a Consultant Neuropsychologist and Head of Neuropsychology working within Neurosciences at Derriford Hospital, Plymouth. He completed the Oxford Doctoral Clinical Psychology training course in 2002 before undertaking post-qualification training in Neuropsychology at the Institute of Psychiatry, Kings College, London. He has a clinical interest in early onset dementia and research interests in the field of cognitive assessment and early detection of dementia. He also conducts clinical trials as part of DeNDRoN and is currently the lead for two studies in Huntington's disease. He loves coffee and surfing although not at the same time.
Dr Steve Pearson - collaborator
Dr Stephen Pearson is a Consultant in Old Age Psychiatry and works in West Devon for Devon Partnership NHS Trust being based in a community multidisciplinary team. He is a longstanding collaborator / supporter of NeuroCoRe. He graduated from Bristol Medical School in 1983 and after a period as Principal in General Practice retrained in Psychiatry on the Peninsula. He conducts clinical trials in Alzheimer Dementia as part of DeNDRoN and is a regional specialist in Huntington's Disease. He is interested in supporting the development computerised assessments of dementia, to further our understanding of dementia disease processes.
Dr Camille Carroll - PD lead
Dr Carroll is a consultant neurologist with a specialist interest in movement disorders and Parkinson's disease. Her research interest is in mechanisms of cell death and neuroprotective strategies, particularly the potential neuroprotective effects of cannabinoids and endocannabinoid modulators. She has active collaborations locally and nationally investigating other aspects of PD pathogenesis including pre-symptomatic bowel alpha-synuclein expression, lysosomal pathways and mitochondrial dysfunction. She has previously contributed to studies of surgical intervention in Parkinson's disease (PD), both in the UK and in the US, and planned and managed a clinical trial of cannabinoids for symptomatic therapy in PD. She is currently part of the NIHR-funded team investigating clinical trial methodology in neurodegenerative diseases, investigating outcome measures of various parameters in PD, including computerised assessments in collaboration with NeuroCore. She is joint PD research director for SW DeNDRoN and as such has responsibility for overseeing clinical research capability in the peninsula and the development of a balanced clinical trial portfolio. She is PI on a number of clinical studies and has overseen the development of a PD DNA bank (1500 samples) and PD clinical research register.
Previous team members and projects
Lucy Palmer: Praxis detection software in Parkinson's Disease. Sarah Bishop: Effort testing in ACEmobile. Emil Vuillermoz: Usability testing ACEmobile. Benjamin McArdle: Alternate inputs - ACEmobile. Thomas Graeme-Drury: Novel indices of measurement - ACEmobile. Thea Dominey: CoReTap and Parkinson's Disease Lucy Gibbs: Novel computerised frontal assessment - empirical study Natasha Rall: Novel computerised PAL assessment in AD